Credit Suisse Raises Eli Lilly Price Target


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Here are three takeaways on Credit Suiss's price target increase of Eli Lilly and Co (NYSE: LLY).

"1. We raise our target price to $65 (from $61).

2. Raising TP Following 3Q 2014, Remain Neutral While Watching Commercial Execution

3. We maintain our Neutral rating on the stock given the stock’s current valuation and look for successful commercial execution of new product launches, most notably Trulicity (dulaglutide)."

Shares of Eli lilly were up fractionally on average volume at $66.48.

Benzinga Color is embargoed from Benzinga Pro. The content above is delayed by 1.5 hours.

To get it live, subscribe to Benzinga Pro.


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorPrice TargetAnalyst RatingsCredit Suisse